Avascular Necrosis Market trends, COVID-19 Impact, Business Opportunities, Strategies, Key Players Analysis and Forecast
Bone cells die due to a lack of blood supply in a condition known as avascular necrosis (AVN). It is also known as osteonecrosis, aseptic necrosis, or ischemic bone necrosis. Because of the irregular joint surface, it frequently results in the collapse of the joint surface and subsequent arthritis. The ends (epiphysis) of long bones such as the femur, upper humerus, and ankle joint bones are affected by avascular necrosis. It usually occurs as a result of a combination of factors, such as metabolic, genetic, increased alcohol consumption, smoking, and other diseases.
An X-ray is commonly used to determine the source of joint pain. However, the most sensitive method for diagnosing avascular necrosis in its early stages is magnetic resonance imaging (MRI). MRI detects chemical changes in the bone marrow and shows avascular necrosis in its early stages, unlike X-rays, bone scans, and computed/computerized tomography (CT) scans.
The global avascular
necrosis market is driven by the rising prevalence of bone diseases
such as osteoarthritis and osteoporosis, as well as rising cases of alcohol
abuse and steroids, and patients' preference for medication over surgery.
However, a majority of people are unaware of the strict regulatory requirements
and lack awareness.
Meanwhile, healthcare providers are continuing to focus on providing low-cost treatment in order to break into regional markets with a higher proportion of price-sensitive patients. The avascular Necrosis Market affects nearly 40% of the world's population, with China and India accounting for nearly half of that. These two countries offer lucrative market opportunities, but unstructured regulatory frameworks and a lack of awareness are two major roadblocks that healthcare providers must overcome in order to provide greater access to medical care in these two countries.
Boehringer Ingelheim GmbH, Eli Lilly and Company, Grifols SA, K-Stemcell Co Ltd., Merck KGaA, Medtronic Plc, Pfizer Inc., Stryker Corporation, Bone Therapeutics, Sanofi SA, Bayer AG, Ethicon Inc., Enzo Biochem Inc., Integra LifeSciences Corporation, Zimmer Biomet Holdings, and Wright Medical Group N.V. are among the major players
Comments
Post a Comment